Hans-Peter Gerber

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ David Pauling as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans-Peter Gerber:

Company Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Restricted Stock Units (RSUs) 75,000 $154,700 $1.36 18 Sep 2025 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Common Stock 71,832 $57,494 $0.8004 15 Oct 2025 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Stock Option (right to buy) 7,925 23 Dec 2025 Direct

Insider Reports Filed by Hans-Peter Gerber

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STRO SUTRO BIOPHARMA, INC. 23 Dec 2025 1 $0 4 CHIEF SCIENTIFIC OFFICER 29 Dec 2025, 16:49
STRO SUTRO BIOPHARMA, INC. 15 Oct 2025 1 +$13,607 4 CHIEF SCIENTIFIC OFFICER 16 Oct 2025, 08:19
STRO SUTRO BIOPHARMA, INC. 18 Sep 2025 3 -$12,075 4 CHIEF SCIENTIFIC OFFICER 22 Sep 2025, 17:01
STRO SUTRO BIOPHARMA, INC. 04 Apr 2025 2 $0 4 CHIEF SCIENTIFIC OFFICER 08 Apr 2025, 16:11
STRO SUTRO BIOPHARMA, INC. 01 Mar 2025 3 -$7,347 4 CHIEF SCIENTIFIC OFFICER 04 Mar 2025, 18:34
STRO SUTRO BIOPHARMA, INC. 18 Sep 2024 3 -$52,851 4 CHIEF SCIENTIFIC OFFICER 20 Sep 2024, 16:09
STRO SUTRO BIOPHARMA, INC. 05 Mar 2024 2 $0 4 CHIEF SCIENTIFIC OFFICER 07 Mar 2024, 16:28
STRO SUTRO BIOPHARMA, INC. 18 Sep 2023 2 $0 4 Chief Scientific Officer 19 Sep 2023, 16:19
STRO SUTRO BIOPHARMA, INC. 18 Sep 2023 0 $0 3 Chief Scientific Officer 19 Sep 2023, 16:15